InMed Pharmaceuticals registers 3.9M shares for resale

6 hours ago 1

InMed Pharmaceuticals (NASDAQ:INM) has filed a prospectus for the resale of up to 3.90M common shares by a selling shareholder and its permitted transferees.
The offering includes 1.95M shares from pre-funded warrants and 1.95M shares from preferred investment options, both issued under a private placement.
InMed will not receive proceeds from the resale of shares but may receive up to $4.76M from the exercise of preferred investment options, and $195 from pre-funded warrants if exercised for cash.
Source: SEC filing

Recommended For You